BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 16949096)

  • 1. Osmolyte trimethylamine N-oxide converts recombinant alpha-helical prion protein to its soluble beta-structured form at high temperature.
    Nandi PK; Bera A; Sizaret PY
    J Mol Biol; 2006 Sep; 362(4):810-20. PubMed ID: 16949096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the osmolyte trimethylamine N-oxide on the stability of the prion protein at low pH.
    Granata V; Palladino P; Tizzano B; Negro A; Berisio R; Zagari A
    Biopolymers; 2006 Jun; 82(3):234-40. PubMed ID: 16489585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-induced partial unfolding of prion protein leads to its polymerisation to amyloid.
    Nandi PK; Leclerc E; Nicole JC; Takahashi M
    J Mol Biol; 2002 Sep; 322(1):153-61. PubMed ID: 12215421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cu(II) induces small-size aggregates with amyloid characteristics in two alleles of recombinant ovine prion proteins.
    Tsiroulnikov K; Rezaei H; Dalgalarrondo M; Chobert JM; Grosclaude J; Haertlé T
    Biochim Biophys Acta; 2006 Jul; 1764(7):1218-26. PubMed ID: 16777497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
    Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
    J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of prion protein oligomerization, aggregation, and beta-sheet conversion by 4,4'-dianilino-1,1'-binaphthyl-5,5'-sulfonate (bis-ANS).
    Cordeiro Y; Lima LM; Gomes MP; Foguel D; Silva JL
    J Biol Chem; 2004 Feb; 279(7):5346-52. PubMed ID: 14634010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual property of prion protein unfolding in neutral salt solution.
    Nandi PK; Leclerc E; Marc D
    Biochemistry; 2002 Sep; 41(36):11017-24. PubMed ID: 12206674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assembly of the full-length recombinant mouse prion protein I. Formation of soluble oligomers.
    Vendrely C; Valadié H; Bednarova L; Cardin L; Pasdeloup M; Cappadoro J; Bednar J; Rinaudo M; Jamin M
    Biochim Biophys Acta; 2005 Aug; 1724(3):355-66. PubMed ID: 15975719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein.
    Morillas M; Vanik DL; Surewicz WK
    Biochemistry; 2001 Jun; 40(23):6982-7. PubMed ID: 11389614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
    Satheeshkumar KS; Jayakumar R
    Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.
    Swietnicki W; Morillas M; Chen SG; Gambetti P; Surewicz WK
    Biochemistry; 2000 Jan; 39(2):424-31. PubMed ID: 10631004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of disulfide bridge in the folding and stability of the recombinant human prion protein.
    Maiti NR; Surewicz WK
    J Biol Chem; 2001 Jan; 276(4):2427-31. PubMed ID: 11069909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structural transition of the prion protein into its pathogenic conformation is induced by unmasking hydrophobic sites.
    Leffers KW; Schell J; Jansen K; Lucassen R; Kaimann T; Nagel-Steger L; Tatzelt J; Riesner D
    J Mol Biol; 2004 Nov; 344(3):839-53. PubMed ID: 15533449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational dynamics of a hydrophobic prion fragment (113-127) in different pH and osmolyte solutions.
    Inayathullah M; Rajadas J
    Neuropeptides; 2016 Jun; 57():9-14. PubMed ID: 26919915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shaking alone induces de novo conversion of recombinant prion proteins to β-sheet rich oligomers and fibrils.
    Ladner-Keay CL; Griffith BJ; Wishart DS
    PLoS One; 2014; 9(6):e98753. PubMed ID: 24892647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of humic substances with the human prion protein fragment 90-231 affects its protease K resistance and cell internalization.
    Corsaro A; Anselmi C; Polano M; Aceto A; Florio T; De Nobili M
    J Biol Regul Homeost Agents; 2010; 24(1):27-39. PubMed ID: 20385069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathway complexity of prion protein assembly into amyloid.
    Baskakov IV; Legname G; Baldwin MA; Prusiner SB; Cohen FE
    J Biol Chem; 2002 Jun; 277(24):21140-8. PubMed ID: 11912192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of alpha-helix in the beta-sheet protein tumor necrosis factor-alpha: thermal- and trifluoroethanol-induced denaturation at neutral pH.
    Narhi LO; Philo JS; Li T; Zhang M; Samal B; Arakawa T
    Biochemistry; 1996 Sep; 35(35):11447-53. PubMed ID: 8784200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slow spontaneous α-to-β structural conversion in a non-denaturing neutral condition reveals the intrinsically disordered property of the disulfide-reduced recombinant mouse prion protein.
    Sang JC; Lee CY; Luh FY; Huang YW; Chiang YW; Chen RP
    Prion; 2012; 6(5):489-97. PubMed ID: 22987112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.